News | Proton Therapy | April 04, 2017

Mevion Installs S250i Proton Therapy System at MedStar Georgetown University Hospital

S250i with Hyperscan allows hyper-fast and ultra-sharp pencil beam scanning

Mevion, S250i proton therapy system, Hyperscan pencil beam scanning, installation, MedStar Georgetown University Hospital

April 4, 2017 — Mevion Medical Systems announced the installation of the first Mevion S250i proton therapy system with Hyperscan pencil beam scanning at MedStar Georgetown University Hospital in Washington, D.C. This technology will allow MedStar Georgetown to deliver enhanced intensity modulated proton therapy (IMPT) by combining fast energy modulation with sharp lateral penumbra, improving the treatment options available to cancer patients.

This is the first installation of Hyperscan with Adaptive Aperture, Mevion’s novel proton multi-leaf collimator. The installation at MedStar Georgetown will be followed by a Mevion S250i installation at Zuidoost Nederland Protonen Therapie Centrum, co-located at the Maastricht Clinic, in the Netherlands, and at the Ackerman Cancer Center in Jacksonville, Fla., the second unit installed at the private, physician-run center.

The Adaptive Aperture is a proprietary low-profile micro-multi-leaf collimator system designed specifically for Hyperscan pencil beam scanning. It eliminates the need for manual apertures and adjustments because its layer-by-layer beam collimation achieves one to three millimeter collimated effective spot sizes for all energies. Hyperscan with Adaptive Aperture is capable of scanning a typical lung tumor in less than two seconds – eliminating many of the challenges caused by patient motion that other pencil beam scanning systems encounter.

Proton therapy provides targeted radiation treatment for many types of cancer, significantly reducing the dose of radiation to healthy tissue by as much as a factor of three, while still maintaining high conformance to the treatment target.

For more information: www.mevion.com

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...